Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS6141340B2 - - Google Patents
[go: Go Back, main page]

JPS6141340B2 - - Google Patents

Info

Publication number
JPS6141340B2
JPS6141340B2 JP4407878A JP4407878A JPS6141340B2 JP S6141340 B2 JPS6141340 B2 JP S6141340B2 JP 4407878 A JP4407878 A JP 4407878A JP 4407878 A JP4407878 A JP 4407878A JP S6141340 B2 JPS6141340 B2 JP S6141340B2
Authority
JP
Japan
Prior art keywords
formula
group
halogen
acid
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP4407878A
Other languages
Japanese (ja)
Other versions
JPS54135741A (en
Inventor
Setsuo Fujii
Hiroyuki Kawamura
Morizo Taira
Ryoji Matsui
Yojiro Sakurai
Toshuki Okutome
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Torii Pharmaceutical Co Ltd
Original Assignee
Torii Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torii Pharmaceutical Co Ltd filed Critical Torii Pharmaceutical Co Ltd
Priority to JP4407878A priority Critical patent/JPS54135741A/en
Priority to US05/917,232 priority patent/US4182897A/en
Priority to NLAANVRAGE7806755,A priority patent/NL177018C/en
Priority to CH681478A priority patent/CH642056A5/en
Priority to DE2827657A priority patent/DE2827657C2/en
Priority to GB7827739A priority patent/GB2000133B/en
Priority to FR7818825A priority patent/FR2395250A1/en
Priority to BE188813A priority patent/BE868414A/en
Publication of JPS54135741A publication Critical patent/JPS54135741A/en
Publication of JPS6141340B2 publication Critical patent/JPS6141340B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は式() The present invention is based on the formula ()

【式】 で示されるアミノフエニルプロピオン酸誘導体お
よびその酸付加塩ならびにその製造方法に関す
る。式中、R1は水素または低級アルキル基を、
R2は低級アルキル基、カルボキシアルキル基も
しくはハロゲンで置換されたフエニル基;ナフチ
ル基;またはハロゲンで置換されたナフチル基を
示す。 本発明の目的は医薬品として有用な物質を得る
ことにある。 本発明の化合物()は、式()で示される
ニトロ桂皮酸と式()で示されるフエノール誘
導体またはナフトール誘導体との通常の脱水縮合
反応により式()で示されるニトロ桂皮酸エス
テル誘導体を製造し、次いで、これを還元するこ
とにより製造することができる。還元手段として
は、たとえば、パラジウム炭素、白金、ラネーニ
ツケル等の接触還元に通常用いる触媒による接触
還元がある。 これを反応式で示せば下記のとおりである。 式中、R1は水素または低級アルキル基を、R2
は低級アルキル基、カルボキシアルキル基もしく
はハロゲンで置換されたフエニル基;ナフチル
基;またはハロゲンで置換されたナフチル基 本発明で使用する原料物質()はニトロベン
ズアルデヒドと低級脂肪酸無水物あるいは低級脂
肪酸エステルとを、パーキン反応、クライゼン反
応としてよく知られている反応に用いる条件によ
り合成することができる。 本発明を実施するにあたつては上記原料物質
()とフエノール誘導体()との通常の脱水
縮合反応によつて化合物()を得ることが出来
る。すなわちDCC(ジシクロヘキシルカーボジ
イミド)法、DPPA(ジフエニルフオスフオリル
アジド)法、混合酸無水物法、酸クロライド法等
通常のよく知られた脱水縮合反応によつて化合物
()を得ることができる。しかし、これらの反
応において操作の難易、経済性、生成物の純度等
の見地から酸クロライド法が、好ましい方法であ
る。酸クロライド法はハロゲン化水素を副生する
反応であり、脱ハロゲン化水素剤、例えば、トリ
エチルアミン、トリブチルアミン、ピリジン等の
有機塩基、炭酸カリウム、炭酸ソーダ等の無機塩
基の存在下に行うのが有利である。使用し得る溶
媒としてはベンゼン、酢酸エチル、エーテル、テ
トラヒドロフラン、ピリジン等があるが、酢酸エ
チルが生成物の純度の点から好ましい。反応は広
い温度範囲にわたり比較的容易に進行する。常温
でまたは少し冷却して行つてもよく、一般に0な
いし30℃の温度で30分ないし1時間で反応は終了
する。 化合物()より本発明の目的化合物であるア
ミノフエニルプロピオン酸エステル()を製造
する場合、化合物()を有機溶媒に溶解又はけ
んだくし、パラジウム炭素、ラネーニツケル、酸
化白金等の触媒の存在下水素ガスを通じることに
より化合物()は容易に合成できる。使用し得
る溶媒としてはエタノール、メタノール、ジメチ
ルホルムアミド、テトラヒドロフラン、エーテル
等があるがエタノール、メタノールが好ましい。
反応は広い温度範囲にわたり比較的容易に進行す
る。常温でまたは少し冷却して行つてもよく、一
般に反応は20ないし40℃の温度で1時間ないし2
時間で終了する。反応液より化合物()を取り
出す場合は通常の処理方法、すなわち反応液より
触媒を去し母液を減圧下濃縮することにより化
合物()を得ることができる。また所望により
酸付加塩を得ることができる。 本発明の化合物は、蛋白分解酵素(トリプシ
ン、トロンビン、C1エステラーゼ、カリクレイ
ン、プラスミン等)に対し酵素阻害活性を有する
ので、これらの酵素に起因する疾病の治療に有用
である。 次に実施例をあげて本発明を説明する。 実施例 1 p−ニトロ桂皮酸19.3gを酢酸エチル300mlに
けんだくし、五塩化リン22gを加え室温下で1時
間かくはんする。反応終了後、溶媒を減圧下留去
するとp−ニトロ桂皮酸クロライドが析出する。
これを酢酸エチル300mlに溶解し、p−クレゾー
ル10.8gを加える。室温でかくはんしつつトリエ
チルアミン12gを徐々に加える。室温で1時間反
応させた後、反応液を10%HCl、10%NaOHおよ
び水で洗浄し、無水硫酸マグネシウムで乾燥し、
溶媒を留去し、p−ニトロ桂皮酸p−メチルフエ
ニルエステルを得る。 収量26.8g、収率95%。融点168〜170℃。IR(cm
-1)1720、1510、1345。 得られたパラニトロ桂皮酸p−メチルフエニル
エステル26.8g、および10%パラジウム炭素2.0
gをエタノール200mlにけんだくし、かくはん
下、水素を通じると2時間で水素ガスを約8.5
吸収する。反応終了後、パラジウムを去し溶媒
を減圧下留去する。残渣をエチルエーテル200ml
に溶解し、塩酸ガスを通じるとp−アミノフエニ
ルプロピオン酸p−メチルフエニルエステル塩酸
塩が無色結晶として析出する。収量24.2g、収率
87.7%、融点203〜205℃(分解)IR.(cm-1
3250〜2500、1745、1506 MS.M+=m/e255(M.W.−HCl) 元素分析 C16H18NO2Cl=291.77として、 理論値 C;65.86%、H;6.22%、N;4.80% 実測値 C;65.96%、H;6.33%、N;4.76% この物質は、in vitroにおいてトロンビンがト
シルアルギニンメチルエステルを水解する作用を
阻害する。この物質が、この水解反応を50%抑制
する濃度は8.8×10-4Mであつた。 実施例 2 p−ニトロ−α−メチル桂皮酸20.7gを酢酸エ
チル300mlにけんだくし、五塩化リン22gを加
え、室温下で1時間かくはんする。反応終了後、
溶媒を減圧下留去するとp−ニトロ−α−メチル
桂皮酸ロライドが析出する。これを酢酸エチル
300mlに溶解しp−クロルフエノール12.5gを加
える。室温で1時間反応させた後反応液を10%
HCl、10%NaOH、水で洗浄し、無水硫酸マグネ
シウムで乾燥し、溶媒を留去し、p−ニトロ−α
−メチル桂皮酸p−クロルフエニルエステルを得
る。収量29.8g、収率93.9%。融点111〜112℃。
IR(cm-1)1721、1512、1342。 得られたp−ニトロ−α−メチル桂皮酸p−ク
ロルフエニルエステル29.8gおよび10%パラジウ
ム炭素3.0gをエタノール250mlにけんだくし、か
くはん下水素ガスを通じると2時間で水素ガスを
約8.5吸収する。反応終了後パラジウムを去
し、溶媒を減圧下留去する。残渣をエチルエーテ
ル200mlに溶解し、塩酸ガスを通じるとp−アミ
ノ−α−メチル−フエニルプロピオン酸p−クロ
ルフエニルエステル塩酸塩が無色結晶として析出
する。収量24.8g、収率81.0%、融点216〜218
℃。 IR(cm-1)3250〜2500、1741、1510、1198 MS.M+=m/e289、291(M.W.−HCl)。 元素分析 C16H17NO2Cl2=326.23として 理論値 C;58.90%、H;5.25%、N;4.29% 実測値 C;58.62%、H;5.10%、N;4.21% この物質は、in vitroにおいてトリプシンがト
シルアルギニンメチルエステルを水解する作用を
阻害する。この物質が、この水解反応を50%抑制
する濃度は3.3×10-4Mであつた。 次に、本発明のアミノフエニルプロピオン酸誘
導体のその他の代表的化合物とその物理恒数を第
1表に示す。
The present invention relates to an aminophenylpropionic acid derivative represented by the formula: an acid addition salt thereof, and a method for producing the same. In the formula, R 1 is hydrogen or a lower alkyl group,
R 2 represents a lower alkyl group, a carboxyalkyl group, or a halogen-substituted phenyl group; a naphthyl group; or a halogen-substituted naphthyl group. An object of the present invention is to obtain a substance useful as a pharmaceutical. The compound () of the present invention is a nitrocinnamic acid ester derivative represented by the formula () produced by a conventional dehydration condensation reaction between the nitrocinnamic acid represented by the formula () and the phenol derivative or naphthol derivative represented by the formula (). It can then be produced by reducing this. Examples of the reduction means include catalytic reduction using catalysts commonly used for catalytic reduction such as palladium on carbon, platinum, and Raney nickel. This reaction formula is shown below. In the formula, R 1 is hydrogen or a lower alkyl group, R 2
is a lower alkyl group, a carboxyalkyl group, or a phenyl group substituted with a halogen; a naphthyl group; or a naphthyl group substituted with a halogen. can be synthesized under the conditions used in well-known reactions such as Perkin reaction and Claisen reaction. In carrying out the present invention, the compound () can be obtained by a conventional dehydration condensation reaction between the above-mentioned raw material () and the phenol derivative (). That is, the compound () can be obtained by a conventional and well-known dehydration condensation reaction such as the DCC (dicyclohexylcarbodiimide) method, the DPPA (diphenylphosphoryl azide) method, the mixed acid anhydride method, or the acid chloride method. . However, in these reactions, the acid chloride method is preferred from the viewpoints of operational difficulty, economic efficiency, product purity, and the like. The acid chloride method is a reaction that produces hydrogen halide as a by-product, and is best carried out in the presence of a dehydrohalogenating agent, such as an organic base such as triethylamine, tributylamine, or pyridine, or an inorganic base such as potassium carbonate or soda carbonate. It's advantageous. Usable solvents include benzene, ethyl acetate, ether, tetrahydrofuran, pyridine, etc., but ethyl acetate is preferred from the viewpoint of product purity. The reaction proceeds relatively easily over a wide temperature range. The reaction may be carried out at room temperature or with slight cooling, and the reaction is generally completed in 30 minutes to 1 hour at a temperature of 0 to 30°C. When producing aminophenyl propionate ester (), which is the target compound of the present invention, from compound (), compound () is dissolved or suspended in an organic solvent, and the compound () is dissolved or suspended in an organic solvent in the presence of a catalyst such as palladium on carbon, Raney nickel, or platinum oxide. Compound () can be easily synthesized by passing hydrogen gas. Examples of solvents that can be used include ethanol, methanol, dimethylformamide, tetrahydrofuran, and ether, with ethanol and methanol being preferred.
The reaction proceeds relatively easily over a wide temperature range. The reaction may be carried out at room temperature or with slight cooling; generally, the reaction is carried out at a temperature of 20 to 40°C for 1 to 2 hours.
Finish in time. When taking out compound () from the reaction solution, compound () can be obtained by a usual treatment method, that is, by removing the catalyst from the reaction solution and concentrating the mother liquor under reduced pressure. Furthermore, acid addition salts can be obtained if desired. The compounds of the present invention have enzyme inhibitory activity against proteolytic enzymes (trypsin, thrombin, C1 esterase, kallikrein, plasmin, etc.) and are therefore useful for treating diseases caused by these enzymes. Next, the present invention will be explained with reference to Examples. Example 1 19.3 g of p-nitrocinnamic acid was suspended in 300 ml of ethyl acetate, 22 g of phosphorus pentachloride was added, and the mixture was stirred at room temperature for 1 hour. After the reaction is completed, the solvent is distilled off under reduced pressure to precipitate p-nitrocinnamic acid chloride.
Dissolve this in 300 ml of ethyl acetate and add 10.8 g of p-cresol. Gradually add 12 g of triethylamine while stirring at room temperature. After reacting for 1 hour at room temperature, the reaction solution was washed with 10% HCl, 10% NaOH and water, dried over anhydrous magnesium sulfate,
The solvent is distilled off to obtain p-nitrocinnamic acid p-methylphenyl ester. Yield 26.8g, yield 95%. Melting point 168-170℃. IR (cm
-1 ) 1720, 1510, 1345. Obtained 26.8 g of para-nitrocinnamic acid p-methylphenyl ester and 2.0 g of 10% palladium on carbon.
When 200ml of ethanol is dissolved in 200ml of ethanol and hydrogen is passed under stirring, approximately 8.5g of hydrogen gas is produced in 2 hours.
Absorb. After the reaction is complete, the palladium is removed and the solvent is distilled off under reduced pressure. Pour the residue into 200ml of ethyl ether.
When hydrochloric acid gas is passed through the solution, p-aminophenylpropionic acid p-methylphenyl ester hydrochloride is precipitated as colorless crystals. Yield 24.2g, yield
87.7%, melting point 203-205℃ (decomposition) IR. (cm -1 )
3250-2500, 1745, 1506 MS.M + = m/e255 (MW-HCl) Elemental analysis C 16 H 18 NO 2 Cl = 291.77, theoretical value C: 65.86%, H: 6.22%, N: 4.80% Actual measurement Values C: 65.96%, H: 6.33%, N: 4.76% This substance inhibits the action of thrombin to hydrolyze tosylarginine methyl ester in vitro. The concentration of this substance that inhibited this hydrolysis reaction by 50% was 8.8×10 −4 M. Example 2 20.7 g of p-nitro-α-methylcinnamic acid was suspended in 300 ml of ethyl acetate, 22 g of phosphorus pentachloride was added, and the mixture was stirred at room temperature for 1 hour. After the reaction is complete,
When the solvent is distilled off under reduced pressure, p-nitro-α-methyl cinnamic acid loride is precipitated. Add this to ethyl acetate
Dissolve in 300ml and add 12.5g of p-chlorophenol. After reacting for 1 hour at room temperature, the reaction solution was reduced to 10%.
Washed with HCl, 10% NaOH, water, dried over anhydrous magnesium sulfate, evaporated the solvent, p-nitro-α
-Methylcinnamic acid p-chlorophenyl ester is obtained. Yield 29.8g, yield 93.9%. Melting point 111-112℃.
IR (cm -1 ) 1721, 1512, 1342. 29.8 g of the obtained p-nitro-α-methylcinnamic acid p-chlorophenyl ester and 3.0 g of 10% palladium on carbon were suspended in 250 ml of ethanol, and hydrogen gas was passed through the mixture while stirring, resulting in approximately 8.5 g of hydrogen gas in 2 hours. Absorb. After the reaction is complete, the palladium is removed and the solvent is distilled off under reduced pressure. The residue was dissolved in 200 ml of ethyl ether and hydrochloric acid gas was passed through the solution to precipitate p-amino-α-methyl-phenylpropionic acid p-chlorophenyl ester hydrochloride as colorless crystals. Yield 24.8g, yield 81.0%, melting point 216-218
℃. IR (cm -1 ) 3250-2500, 1741, 1510, 1198 MS.M + = m/e 289, 291 (MW-HCl). Elemental analysis C 16 H 17 NO 2 Cl 2 = 326.23 Theoretical value C: 58.90%, H: 5.25%, N: 4.29% Actual value C: 58.62%, H: 5.10%, N: 4.21% This substance is in Inhibits trypsin's hydrolysis of tosylarginine methyl ester in vitro. The concentration of this substance that inhibited this hydrolysis reaction by 50% was 3.3×10 −4 M. Next, Table 1 shows other representative compounds of the aminophenylpropionic acid derivatives of the present invention and their physical constants.

【表】【table】

【表】【table】

【表】【table】

Claims (1)

【特許請求の範囲】 1 式() (式中、R1は水素または低級アルキル基を、R2
低級アルキル基、カルボキシアルキル基もしくは
ハロゲンで置換されたフエニル基;ナフチル基;
またはハロゲンで置換されたナフチル基を示す)
で示されるアミノフエニルプロピオン酸誘導体お
よびその酸付加塩。 2 式() で示されるニトロ桂皮酸誘導体と式() HO−R2 () で示されるフエノール誘導体またはナフトール誘
導体との通常の脱水縮合反応により式() で示されるニトロ桂皮酸エステル誘導体を製造
し、次いでこの化合物を還元し、所望により塩に
変換することを特徴とする式() (上記各式中、R1は水素または低級アルキル基
を、R2は低級アルキル基、カルボキシアルキル
基もしくはハロゲンで置換されたフエニル基;ナ
フチル基;またはハロゲンで置換されたナフチル
基を示す)で示されるアミノフエニルプロピオン
酸誘導体およびその酸付加塩の製造方法。 3 式() で示されるニトロ桂皮酸エステル誘導体を還元
し、所望により塩に変換することを特徴とする式
() (上記各式中、R1は水素または低級アルキル基
を、R2は低級アルキル基、カルボキシアルキル
基もしくはハロゲンで置換されたフエニル基;ナ
フチル基;またはハロゲンで置換されたナフチル
基を示す)で示されるアミノフエニルプロピオン
酸誘導体およびその酸付加塩の製造方法。
[Claims] 1 Formula () (In the formula, R 1 is hydrogen or a lower alkyl group, R 2 is a lower alkyl group, a carboxyalkyl group, or a phenyl group substituted with a halogen; a naphthyl group;
or halogen-substituted naphthyl group)
Aminophenylpropionic acid derivatives and acid addition salts thereof. 2 formula () The formula () is obtained by a conventional dehydration condensation reaction between the nitrocinnamic acid derivative represented by the formula () and the phenol derivative or naphthol derivative represented by the formula () HO−R 2 (). Formula () characterized in that a nitrocinnamic acid ester derivative represented by is produced, and then this compound is reduced and optionally converted into a salt. (In each of the above formulas, R 1 represents hydrogen or a lower alkyl group, and R 2 represents a lower alkyl group, a carboxyalkyl group, or a phenyl group substituted with a halogen; a naphthyl group; or a naphthyl group substituted with a halogen). A method for producing the aminophenylpropionic acid derivative and its acid addition salt. 3 formula () Formula () characterized in that the nitrocinnamic acid ester derivative represented by is reduced and optionally converted into a salt. (In each of the above formulas, R 1 represents hydrogen or a lower alkyl group, and R 2 represents a lower alkyl group, a carboxyalkyl group, or a phenyl group substituted with a halogen; a naphthyl group; or a naphthyl group substituted with a halogen). A method for producing the aminophenylpropionic acid derivative and its acid addition salt.
JP4407878A 1977-06-24 1978-04-14 Phenylpropionic acid derivative Granted JPS54135741A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
JP4407878A JPS54135741A (en) 1978-04-14 1978-04-14 Phenylpropionic acid derivative
US05/917,232 US4182897A (en) 1977-06-24 1978-06-20 Amino- or guanidino-phenylpropionic acid derivatives
NLAANVRAGE7806755,A NL177018C (en) 1977-06-24 1978-06-22 PHENYLPROPIONIC ACID DERIVATIVES, AND SUCH DERIVATIVES CONTAINING PHARMACEUTICAL PREPARATIONS.
CH681478A CH642056A5 (en) 1977-06-24 1978-06-22 THERAPEUTICALLY ACTIVE AMINO OR GUANIDINO PHENYL PROPIONIC ACID ESTER DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF.
DE2827657A DE2827657C2 (en) 1977-06-24 1978-06-23 Amino- or guanidino-phenylpropionic acid ester derivatives, processes for their preparation and medicaments containing these compounds
GB7827739A GB2000133B (en) 1977-06-24 1978-06-23 Amino-and guanidino-phenylpropionic acid derivatives process for their preparation and pharmaceutical compositions containing them
FR7818825A FR2395250A1 (en) 1977-06-24 1978-06-23 DERIVATIVES OF AMINO- GUANIDINO-PHENYLPROPIONIC ACIDS
BE188813A BE868414A (en) 1977-06-24 1978-06-23 NEW AMINO-OR GUANIDINO-PHENYL-PROPIONIC ESTERS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4407878A JPS54135741A (en) 1978-04-14 1978-04-14 Phenylpropionic acid derivative

Publications (2)

Publication Number Publication Date
JPS54135741A JPS54135741A (en) 1979-10-22
JPS6141340B2 true JPS6141340B2 (en) 1986-09-13

Family

ID=12681579

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4407878A Granted JPS54135741A (en) 1977-06-24 1978-04-14 Phenylpropionic acid derivative

Country Status (1)

Country Link
JP (1) JPS54135741A (en)

Also Published As

Publication number Publication date
JPS54135741A (en) 1979-10-22

Similar Documents

Publication Publication Date Title
JPS6150941B2 (en)
JPS6141340B2 (en)
JPH05286889A (en) Production of arylacetic acid and its alkali metal salt
JPH0421674A (en) Production of 2-chloro-5-(aminomethyl)thiazole
JP2855871B2 (en) Method for producing thiomalic acid
JP3899626B2 (en) Preparation of 2-mercaptothiazol
JPS6053039B2 (en) N-Acetyl/Iramic acid derivative and method for producing the same
JPH06340622A (en) Production of benzylsuccinic acid derivative and intermediate for its synthesis
JPH0352839A (en) Production of p-or m-tert-butoxybenzaldehyde
JPS6141508B2 (en)
JP3299322B2 (en) Method for producing tetramethoxymethylbenzaldehyde
JP3258850B2 (en) Method for producing 5-substituted dihydrouracils
JPH0478638B2 (en)
JPS6026101B2 (en) Phenylpropionic acid derivatives
JPS6026098B2 (en) Phenylpropionic acid derivatives
JP2716243B2 (en) N-benzyl-3-hydroxysuccinamic acid and method for producing the same
JPS6026395B2 (en) Synthesis method of N-trialkylsilylmethylurea
JPH0146502B2 (en)
JPS6337104B2 (en)
JPH0527617B2 (en)
JPH0812658A (en) Production of sydnones
JPH0344349A (en) Production of p-or m-hydroxybenzaldehyde
JPH0296555A (en) Production of 4-carboxyamidecyclohexane carboxylic acid esters
JPS634546B2 (en)
JPH10310568A (en) N-alkoxycarbonyl-L-asparagine